Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 144481-98-1
2. Landiolol Hcl
3. Ono 1101 Hydrochloride
4. Ono-1101 Hydrochloride
5. Landiolol Related Impurity 4
6. ((s)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-((s)-2-hydroxy-3-((2-(morpholine-4-carboxamido)ethyl)amino)propoxy)phenyl)propanoate Hydrochloride
7. G8hq634y17
8. Ldll600
9. Landiolol (hydrochloride)
10. Dsstox_cid_28531
11. Dsstox_rid_82803
12. Dsstox_gsid_48605
13. [(4s)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2s)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate;hydrochloride
14. Landiolol Hydrochloride (jan)
15. Landiolol Hydrochloride [jan]
16. ((s)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-((s)-2-hydroxy-3-((2-(morpholine-4-carboxamido)ethyl)amino)propoxy)phenyl)propanoate Hcl
17. Cas-144481-98-1
18. Ncgc00182709-01
19. Ncgc00182709-02
20. Onoact
21. Unii-g8hq634y17
22. Onoact (tn)
23. Landiolol Hydrochloride [usan]
24. Chembl2362410
25. Dtxsid3048605
26. Chebi:31760
27. Landiolol Hydrochloride [mi]
28. Tox21_112940
29. Tox21_113021
30. Mfcd01937430
31. S5540
32. Akos025311253
33. Tox21_113021_1
34. Ccg-269982
35. Hy-100607a
36. Landiolol Hydrochloride [mart.]
37. Landiolol Hydrochloride [who-dd]
38. Ncgc00182709-03
39. Ac-22604
40. As-17684
41. Benzenepropanoic Acid, 4-(2-hydroxy-3-((2-((4-morpholinylcarbonyl)amino)ethyl)amino)propoxy)-, (2,2-dimethyl-1,3-dioxolan-4-yl)methyl Ester, (s-(r*,r*))-, Hydrochloride
42. Landiolol Hydrochloride, >=98% (hplc)
43. Cs-0019761
44. L0296
45. D01847
46. A808219
47. Q27278937
48. 4-((s)-2-hydroxy-3-((2-((morpholinocarbonyl)amino)ethyl)amino)propoxy)benzenepropanoic Acid ((s)-2,2-dimethyl-1,3-dioxolane-4alpha-yl)methyl Hydrochloric Acid
49. Benzenepropanoic Acid, 4-[(2s)-2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-, [(4s)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl Ester, Hydrochloride (1:1)
Molecular Weight | 546.1 g/mol |
---|---|
Molecular Formula | C25H40ClN3O8 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 14 |
Exact Mass | 545.2503929 g/mol |
Monoisotopic Mass | 545.2503929 g/mol |
Topological Polar Surface Area | 128 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 666 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of supraventricular arrhythmias
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : RX
Registration Country : USA
Brand Name : RAPIBLYK
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 280MG BASE/VIAL
Packaging :
Approval Date : 2024-11-22
Application Number : 217202
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Japan
Brand Name :
Dosage Form : Powder for Injection
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Japan
Regulatory Info :
Registration Country : Japan
Brand Name :
Dosage Form : Powder for Injection
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Japan
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 12.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Regulatory Info :
Registration Country : Japan
Brand Name : Onoact
Dosage Form : Intravenous Infusion
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Japan
Regulatory Info :
Registration Country : Japan
Brand Name : Onoact
Dosage Form : Intravenous Infusion
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Japan
Regulatory Info :
Registration Country : Japan
Brand Name : Corebeta
Dosage Form : Powder for Injection
Dosage Strength : 12.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Japan
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SIBBORAN
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 300MG/VIAL
Packaging :
Approval Date :
Application Number : 2543338
Regulatory Info : Prescription
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
84
PharmaCompass offers a list of Landiolol Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Landiolol Hydrochloride manufacturer or Landiolol Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Landiolol Hydrochloride manufacturer or Landiolol Hydrochloride supplier.
PharmaCompass also assists you with knowing the Landiolol Hydrochloride API Price utilized in the formulation of products. Landiolol Hydrochloride API Price is not always fixed or binding as the Landiolol Hydrochloride Price is obtained through a variety of data sources. The Landiolol Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Landiolol HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Landiolol HCl, including repackagers and relabelers. The FDA regulates Landiolol HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Landiolol HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Landiolol HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Landiolol HCl supplier is an individual or a company that provides Landiolol HCl active pharmaceutical ingredient (API) or Landiolol HCl finished formulations upon request. The Landiolol HCl suppliers may include Landiolol HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Landiolol HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Landiolol HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Landiolol HCl active pharmaceutical ingredient (API) in detail. Different forms of Landiolol HCl DMFs exist exist since differing nations have different regulations, such as Landiolol HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Landiolol HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Landiolol HCl USDMF includes data on Landiolol HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Landiolol HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Landiolol HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Landiolol HCl Drug Master File in Japan (Landiolol HCl JDMF) empowers Landiolol HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Landiolol HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Landiolol HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Landiolol HCl suppliers with JDMF on PharmaCompass.
A Landiolol HCl written confirmation (Landiolol HCl WC) is an official document issued by a regulatory agency to a Landiolol HCl manufacturer, verifying that the manufacturing facility of a Landiolol HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Landiolol HCl APIs or Landiolol HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Landiolol HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Landiolol HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Landiolol HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Landiolol HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Landiolol HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Landiolol HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Landiolol HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Landiolol HCl suppliers with NDC on PharmaCompass.
Landiolol HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Landiolol HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Landiolol HCl GMP manufacturer or Landiolol HCl GMP API supplier for your needs.
A Landiolol HCl CoA (Certificate of Analysis) is a formal document that attests to Landiolol HCl's compliance with Landiolol HCl specifications and serves as a tool for batch-level quality control.
Landiolol HCl CoA mostly includes findings from lab analyses of a specific batch. For each Landiolol HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Landiolol HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Landiolol HCl EP), Landiolol HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Landiolol HCl USP).